Irbesartan use in specific populations

Revision as of 17:39, 20 February 2014 by ShiSheng (talk | contribs) (Created page with "__NOTOC__ {{Irbesartan}} {{CMG}}; {{AE}} {{SS}} =Use In Specific Populations== <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = AVAPRO (IRBESARTA...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Irbesartan
AVAPRO® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Irbesartan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Use In Specific Populations=

[1]

References

  1. ↑ "AVAPRO (IRBESARTAN) TABLET [SANOFI-AVENTIS U.S. LLC]". Retrieved 20 February 2014.

Template:Angiotensin II receptor antagonists

Retrieved from "https://www.wikidoc.org/index.php?title=Irbesartan_use_in_specific_populations&oldid=945721"